These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
237 related articles for article (PubMed ID: 31268774)
1. Tsoi M; Morin M; Rico C; Johnson RL; Paquet M; Gévry N; Boerboom D FASEB J; 2019 Oct; 33(10):10819-10832. PubMed ID: 31268774 [TBL] [Abstract][Full Text] [Related]
2. Lats1 and Lats2 regulate YAP and TAZ activity to control the development of mouse Sertoli cells. Abou Nader N; Charrier L; Meisnsohn MC; Banville L; Deffrennes B; St-Jean G; Boerboom D; Zamberlam G; Brind'Amour J; Pépin D; Boyer A FASEB J; 2024 May; 38(9):e23633. PubMed ID: 38690712 [TBL] [Abstract][Full Text] [Related]
3. Targeted Disruption of Lats1 and Lats2 in Mice Impairs Testis Development and Alters Somatic Cell Fate. Abou Nader N; Ménard A; Levasseur A; St-Jean G; Boerboom D; Zamberlam G; Boyer A Int J Mol Sci; 2022 Nov; 23(21):. PubMed ID: 36362374 [TBL] [Abstract][Full Text] [Related]
4. Inactivation of Lats1 and Lats2 highlights the role of hippo pathway effector YAP in larynx and vocal fold epithelium morphogenesis. Mohad V; Lungova V; Verheyden J; Thibeault SL Dev Biol; 2021 May; 473():33-49. PubMed ID: 33515576 [TBL] [Abstract][Full Text] [Related]
5. Timely expression and activation of YAP1 in granulosa cells is essential for ovarian follicle development. Lv X; He C; Huang C; Wang H; Hua G; Wang Z; Zhou J; Chen X; Ma B; Timm BK; Maclin V; Dong J; Rueda BR; Davis JS; Wang C FASEB J; 2019 Sep; 33(9):10049-10064. PubMed ID: 31199671 [TBL] [Abstract][Full Text] [Related]
6. Large tumor suppressor homologs 1 and 2 regulate mouse liver progenitor cell proliferation and maturation through antagonism of the coactivators YAP and TAZ. Yi J; Lu L; Yanger K; Wang W; Sohn BH; Stanger BZ; Zhang M; Martin JF; Ajani JA; Chen J; Lee JS; Song S; Johnson RL Hepatology; 2016 Nov; 64(5):1757-1772. PubMed ID: 27531557 [TBL] [Abstract][Full Text] [Related]
7. Hippo pathway-mediated YAP1/TAZ inhibition is essential for proper pancreatic endocrine specification and differentiation. Wu Y; Qin K; Xu Y; Rajhans S; Vo T; Lopez KM; Liu J; Nipper MH; Deng J; Yin X; Ramjit LR; Ye Z; Luan Y; Arda HE; Wang P Elife; 2024 Jul; 13():. PubMed ID: 39051998 [TBL] [Abstract][Full Text] [Related]
8. WWC1 and NF2 Prevent the Development of Intrahepatic Cholangiocarcinoma by Regulating YAP/TAZ Activity through LATS in Mice. Park J; Kim JS; Nahm JH; Kim SK; Lee DH; Lim DS Mol Cells; 2020 May; 43(5):491-499. PubMed ID: 32451369 [TBL] [Abstract][Full Text] [Related]
9. An evolutionarily conserved negative feedback mechanism in the Hippo pathway reflects functional difference between LATS1 and LATS2. Park GS; Oh H; Kim M; Kim T; Johnson RL; Irvine KD; Lim DS Oncotarget; 2016 Apr; 7(17):24063-75. PubMed ID: 27006470 [TBL] [Abstract][Full Text] [Related]
10. Targeted Disruption of Lats1 and Lats2 in Mice Impairs Adrenal Cortex Development and Alters Adrenocortical Cell Fate. Ménard A; Abou Nader N; Levasseur A; St-Jean G; Le Roy MLG; Boerboom D; Benoit-Biancamano MO; Boyer A Endocrinology; 2020 May; 161(5):. PubMed ID: 32243503 [TBL] [Abstract][Full Text] [Related]
11. A YAP/TAZ-induced feedback mechanism regulates Hippo pathway homeostasis. Moroishi T; Park HW; Qin B; Chen Q; Meng Z; Plouffe SW; Taniguchi K; Yu FX; Karin M; Pan D; Guan KL Genes Dev; 2015 Jun; 29(12):1271-84. PubMed ID: 26109050 [TBL] [Abstract][Full Text] [Related]
12. [Mechanism of resveratrol in protecting ovary in poor ovarian response mice by regulating Hippo signaling pathway]. Hao JH; Chang BY; Ren J; Wang HJ; Ji LX Zhongguo Zhong Yao Za Zhi; 2024 Feb; 49(3):744-753. PubMed ID: 38621878 [TBL] [Abstract][Full Text] [Related]
13. Induction of miR-15a expression by tripterygium glycosides caused premature ovarian failure by suppressing the Hippo-YAP/TAZ signaling effector Lats1. Ai A; Xiong Y; Wu B; Lin J; Huang Y; Cao Y; Liu T Gene; 2018 Dec; 678():155-163. PubMed ID: 30092342 [TBL] [Abstract][Full Text] [Related]
14. Hippo-YAP/TAZ signalling coordinates adipose plasticity and energy balance by uncoupling leptin expression from fat mass. Choi S; Kang JG; Tran YTH; Jeong SH; Park KY; Shin H; Kim YH; Park M; Nahmgoong H; Seol T; Jeon H; Kim Y; Park S; Kim HJ; Kim MS; Li X; Bou Sleiman M; Lee E; Choi J; Eisenbarth D; Lee SH; Cho S; Moore DD; Auwerx J; Kim IY; Kim JB; Park JE; Lim DS; Suh JM Nat Metab; 2024 May; 6(5):847-860. PubMed ID: 38811804 [TBL] [Abstract][Full Text] [Related]
15. Lats1/2 Regulate Yap/Taz to Control Nephron Progenitor Epithelialization and Inhibit Myofibroblast Formation. McNeill H; Reginensi A J Am Soc Nephrol; 2017 Mar; 28(3):852-861. PubMed ID: 27647853 [TBL] [Abstract][Full Text] [Related]
16. Alterations in the NF2/LATS1/LATS2/YAP Pathway in Schwannomas. Oh JE; Ohta T; Satomi K; Foll M; Durand G; McKay J; Le Calvez-Kelm F; Mittelbronn M; Brokinkel B; Paulus W; Ohgaki H J Neuropathol Exp Neurol; 2015 Oct; 74(10):952-9. PubMed ID: 26360373 [TBL] [Abstract][Full Text] [Related]
17. Angiomotins stimulate LATS kinase autophosphorylation and act as scaffolds that promote Hippo signaling. Mana-Capelli S; McCollum D J Biol Chem; 2018 Nov; 293(47):18230-18241. PubMed ID: 30266805 [TBL] [Abstract][Full Text] [Related]
18. Heat shock protein 90 inhibition depletes LATS1 and LATS2, two regulators of the mammalian hippo tumor suppressor pathway. Huntoon CJ; Nye MD; Geng L; Peterson KL; Flatten KS; Haluska P; Kaufmann SH; Karnitz LM Cancer Res; 2010 Nov; 70(21):8642-50. PubMed ID: 20841485 [TBL] [Abstract][Full Text] [Related]
19. Li L; Dong L; Wang Y; Zhang X; Yan J Biomed Res Int; 2018; 2018():4387932. PubMed ID: 30671453 [TBL] [Abstract][Full Text] [Related]
20. LATS-YAP/TAZ controls lineage specification by regulating TGFβ signaling and Hnf4α expression during liver development. Lee DH; Park JO; Kim TS; Kim SK; Kim TH; Kim MC; Park GS; Kim JH; Kuninaka S; Olson EN; Saya H; Kim SY; Lee H; Lim DS Nat Commun; 2016 Jun; 7():11961. PubMed ID: 27358050 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]